Norway extends pause of AstraZeneca vaccine until April 15: health authority

Norway on Friday extended a suspension of the use of the AstraZeneca COVID-19 vaccine until April 15, with health officials saying they needed more time to investigate a potential link to severe blood clotting.

“It is a difficult but correct decision to extend the pause for the AstraZeneca vaccine. We believe it is necessary to carry out more investigations into these cases,” Geir Bukholm, Director of the Division of Infection Control at the Norwegian Institute of Public Health (FHI), said in a statement.

EU drugs regulator EMA last week said the vaccine was “safe and effective” and not linked to a higher risk of blood clots, but could not “rule out definitively” its role in the rare clotting disorder.

© 2021 AFP

• About the Author
• Latest Posts

About healthfortnight

• COVID case rates hit new high for England, study finds - April 7, 2022
• Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
• SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
• Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
• Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
• Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
• LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
• ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
• No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
• Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022